Article info

Download PDFPDF
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis

Authors

  • Sara Sabbagh Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases,National Institutes of Health (NIH), Bethesda, MD, United States PubMed articlesGoogle scholar articles
  • Iago Pinal-Fernandez Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases,National Institutes of Health (NIH), Bethesda, MD, United States Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States Faculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Takayuki Kishi Environmental Autoimmunity Group, National Institute of EnvironmentalHealth Sciences, National Institutes of Health (NIH), Bethesda, MD, United States PubMed articlesGoogle scholar articles
  • Ira N Targoff VA Medical Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States PubMed articlesGoogle scholar articles
  • Frederick W Miller Environmental Autoimmunity Group, National Institute of EnvironmentalHealth Sciences, National Institutes of Health (NIH), Bethesda, MD, United States PubMed articlesGoogle scholar articles
  • Lisa G Rider Environmental Autoimmunity Group, National Institute of EnvironmentalHealth Sciences, National Institutes of Health (NIH), Bethesda, MD, United States PubMed articlesGoogle scholar articles
  • Andrew Lee Mammen Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases,National Institutes of Health (NIH), Bethesda, MD, United States Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Andrew Lee Mammen, NIAMS/NIH, Bethesda, MD 20892, USA; andrew.mammen{at}nih.gov
View Full Text

Citation

Sabbagh S, Pinal-Fernandez I, Kishi T The Childhood Myositis Heterogeneity Collaborative Study Group, et al
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis

Publication history

  • Received December 31, 2018
  • Revised March 8, 2019
  • Accepted April 1, 2019
  • First published April 24, 2019.
Online issue publication 
June 12, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.